Skip to content

IPSC

Century Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.86
−1.06%
Ask drillr
0
Insider buys (3m)
5
Insider sells (3m)
-$10.4K
Net value (3m)
-20.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 15, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind13,850$1.94
Sep 15, 2026Russotti Gregory · officer: See RemarksSale2,587$1.93
Sep 15, 2026Carr Douglas · officer: SVP Finance & OperationsSale1,658$1.93
Sep 10, 2026Truitt Joseph · directorA-Award148,000$2.03
Sep 9, 2026Carr Douglas · officer: SVP Finance & OperationsSale254$2.05
Sep 9, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind463$2.11
Sep 9, 2026Russotti Gregory · officer: See RemarksSale534$2.05
Aug 18, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind31,172$1.92
Aug 5, 2026Carr Douglas · officer: SVP Finance & OperationsSale275$1.98
Jun 15, 2026Russotti Gregory · officer: See RemarksSale2,584$2.23
Jun 15, 2026Carr Douglas · officer: SVP Finance & OperationsSale1,654$2.23
Jun 15, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind13,849$2.24
Jun 15, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind358$2.24
Jun 12, 2026Murphy Martin Patrick · directorA-Award74,000$2.24
Jun 12, 2026Blackwell Kimberly · directorA-Award74,000$2.24
Jun 12, 2026Riva Alessandro · directorA-Award74,000$2.24
Jun 12, 2026Quimi Daphne · directorA-Award74,000$2.24
Jun 12, 2026Lee Han Myung · directorA-Award74,000$2.24
Jun 9, 2026Carr Douglas · officer: SVP Finance & OperationsSale249$2.11
Jun 9, 2026Russotti Gregory · officer: See RemarksSale524$2.11
Jun 9, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind463$2.13
May 19, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind31,172$2.34
May 6, 2026Carr Douglas · officer: SVP Finance & OperationsSale264$2.34
Apr 10, 2026Murphy Martin Patrick · directorA-Award88,000$0.59
Apr 3, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind1,365$2.19
Mar 16, 2026Carr Douglas · officer: SVP Finance & OperationsSale7,043$2.55
Mar 16, 2026Russotti Gregory · officer: See RemarksSale10,076$2.55
Mar 13, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind55,397$2.73
Mar 13, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind1,431$2.73
Mar 11, 2026Russotti Gregory · officer: See RemarksSale479$2.54
Institutional positioning

13F filings over the trailing two quarters

New 69Increased 47Reduced 25Sold out 11
FilerActionSharesFiled
TCG CROSSOVER MANAGEMENT, LLCNew Position17,754,430May 15, 2026
RA CAPITAL MANAGEMENT, L.P.New Position17,754,430May 15, 2026
TCG Crossover Management, LLCUnchanged17,754,430Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged17,754,430Aug 14, 2026
Versant Venture Management, LLCUnchanged12,166,109Aug 12, 2026
VERSANT VENTURE MANAGEMENT, LLCNew Position12,166,109May 5, 2026
DEEP TRACK CAPITAL, LPNew Position9,487,745May 15, 2026
Deep Track Capital, LPReduced9,462,645Aug 14, 2026
COMMODORE CAPITAL LPNew Position8,695,652May 15, 2026
RTW INVESTMENTS, LPUnchanged8,695,652Aug 14, 2026
Commodore Capital LPUnchanged8,695,652Aug 14, 2026
VR ADVISER, LLCNew Position8,695,652May 15, 2026
VR Adviser, LLCUnchanged8,695,652Aug 14, 2026
RTW INVESTMENTS, LPNew Position8,695,652May 15, 2026
BlackRock, Inc.Increased8,091,768Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026